India Globalization Capital, Inc.
(NYSE Amex Equities : IGC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. 1.16%246.641.3%$805.10m
IMMUImmunomedics, Inc. 0.02%85.3811.0%$697.35m
MRNAModerna, Inc. 1.86%70.760.0%$678.86m
NVAXNovavax, Inc. -3.05%110.1096.5%$609.84m
ILMNIllumina, Inc. 1.49%304.343.5%$591.44m
GILDGilead Sciences, Inc. 0.97%62.861.0%$579.74m
REGNRegeneron Pharmaceuticals, Inc. -1.50%565.482.7%$436.76m
BIIBBiogen, Inc. 2.91%281.241.6%$344.73m
VRTXVertex Pharmaceuticals, Inc. -0.06%268.011.9%$340.64m
ALXNAlexion Pharmaceuticals, Inc. -0.73%113.592.0%$283.12m
EXASEXACT Sciences Corp. 2.39%100.0320.7%$263.43m
SRNESorrento Therapeutics, Inc. 5.97%10.211.5%$255.24m
SGENSeattle Genetics, Inc. 2.57%189.706.0%$217.59m
VXRTVaxart, Inc. -5.27%7.010.0%$202.61m
MNTAMomenta Pharmaceuticals, Inc. 0.08%52.443.0%$193.73m

Company Profile

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.